Blume-Jensen Peter

President and CEO at ACRV

Sold, on record
$34k
Dollars the filings state
Form 4 sales
2
Latest Nov 17, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ACRVAcrivon Therapeutics, Inc.President and CEO

Sales by reason

0
Routine
0
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ACRVNo plan
    Aug 25 2026

    Sold 14,036 shares at $2.21 ($31k)

    Blume-Jensen Peter, President and CEO

    No 10b5-1 planSold 0.6% of holdings ($5M position)2.2M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ACRVNo plan
    Nov 17 +84 days

    Sold 1,780 shares at $1.45 ($3k)

    Blume-Jensen Peter, President and CEO

    No 10b5-1 planSold 0.1% of holdings ($3.2M position)2.2M shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Blume-Jensen Peter
Source
Nov 17, 2026ACRVPresident and CEOForm 4 sale1,780$3k0.1%No planSEC
Aug 25, 2026ACRVPresident and CEOForm 4 sale14,036$31k0.6%No planSEC